Eli Lilly is at the forefront of the GLP-1 weight loss drug market. The company’s leading position is already being tested by Novo Nordisk’s GLP-1 weight loss pill.
Source: https://www.fool.com/investing/2026/01/23/forget-eli-lilly-b…
Here is how Banzai International, Inc. (BNZI) and Byrna Technologies Inc. (BYRN) have performed compared to their sector so far this year.
Here is how Acurx Pharmaceuticals, Inc. (ACXP) and Adial Pharmaceuticals, Inc. (ADIL) have performed compared to their sector so far this year.
LAND, NABZY and F made it to the Zacks Rank #1 (Strong Buy) income stocks list on Jan.13, 2026.
